sulfinpyrazone has been researched along with Constriction, Pathologic in 3 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Constriction, Pathologic: The condition of an anatomical structure's being constricted beyond normal dimensions.
Excerpt | Relevance | Reference |
---|---|---|
"Treatment with sulfinpyrazone (800 mg/day) was started 24 hours after operation in 130 patients; 125 patients received placebo." | 2.65 | Effects of sulfinpyrazone on early graft closure after myocardial revascularization. ( Baur, HR; Gobel, FL; Pierach, CA; VanTassel, RA, 1982) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baur, HR | 1 |
VanTassel, RA | 1 |
Pierach, CA | 1 |
Gobel, FL | 1 |
Bolli, R | 1 |
Goldstein, RE | 2 |
Davenport, N | 2 |
Epstein, SE | 2 |
Capurro, N | 1 |
Lipson, LC | 1 |
Bonow, RO | 1 |
Shulman, NR | 1 |
1 trial available for sulfinpyrazone and Constriction, Pathologic
Article | Year |
---|---|
Effects of sulfinpyrazone on early graft closure after myocardial revascularization.
Topics: Constriction, Pathologic; Coronary Circulation; Coronary Vessels; Female; Humans; Male; Middle Aged; | 1982 |
2 other studies available for sulfinpyrazone and Constriction, Pathologic
Article | Year |
---|---|
Influence of sulfinpyrazone and naproxen on infarct size in the dog.
Topics: Animals; Constriction, Pathologic; Coronary Vessels; Dogs; Dose-Response Relationship, Drug; Female; | 1981 |
Sulfinpyrazone and aspirin increase epicardial coronary collateral flow in dogs.
Topics: Animals; Aspirin; Blood Pressure; Collateral Circulation; Constriction, Pathologic; Coronary Vessels | 1981 |